J2351 — Inj Ocrelizumab 1mg Hya-ocsq
$218,169
All-payer median here
$509,060
Cash / self-pay here
36
payer/plan-name variants
Median over current-blob negotiated rates (COALESCE of standard / median / min–max midpoint, $0.01–$5M sentinel guard). Payers are canonical-grouped where a mapping exists; unmapped regional-plan name variants may appear as separate rows.